<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37466098</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-4598</ISSN><JournalIssue CitedMedium="Internet"><Volume>68</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Muscle &amp; nerve</Title><ISOAbbreviation>Muscle Nerve</ISOAbbreviation></Journal><ArticleTitle>Spatial clustering of amyotrophic lateral sclerosis in Sardinia, Italy: The contribution of age, sex, and genetic factors.</ArticleTitle><Pagination><StartPage>323</StartPage><EndPage>328</EndPage><MedlinePgn>323-328</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/mus.27939</ELocationID><Abstract><AbstractText Label="INTRODUCTION/AIMS">Several microgeographic clusters of higher/lower incidence of amyotrophic lateral sclerosis (ALS) have been identified worldwide. Differences in the distribution of local factors were proposed to explain the excess ALS risk, whereas the contribution of known genetic/epigenetic factors remains unclear. The aim is to identify restricted areas of higher risk in Sardinia and to assess whether age, sex, and the most common causative genetic mutations in Sardinia (C9orf72 and TARDBP mutations) contributed to the variation in the ALS risk.</AbstractText><AbstractText Label="METHODS">We performed an ad hoc analysis of the 10-y population-based incident cohort of ALS cases from a recent study of a large Sardinian area. Cluster analysis was performed by age- and sex-adjusted Kulldorff's spatial scan statistic.</AbstractText><AbstractText Label="RESULTS">We identified a statistically significant cluster of higher ALS incidence in a relatively large area including 34 municipalities and &gt;100,000 individuals. The investigated genetic mutations were more frequent in the cluster area than outside. Regardless of the genetic mutations, the excess of ALS risk was significantly associated with either sex or with age&#x2009;&#x2265;&#x2009;65&#x2009;y. Finally, an additive interaction between older age and male sex contributed to the excess of ALS risk in the cluster area but not outside.</AbstractText><AbstractText Label="DISCUSSION">Our analysis demonstrated that known genetic factors, age, and sex may contribute to microgeographic variation in ALS incidence. The significant additive interaction between older age and male sex we found in the high-incidence cluster could suggest the presence of a third factor connecting the analyzed risk factors.</AbstractText><CopyrightInformation>&#xa9; 2023 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Borghero</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute of Neurology, University Hospital of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sechi</LastName><ForeName>Maria Margherita</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Institute of Neurology, University Hospital of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vasta</LastName><ForeName>Rosario</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Amyotrophic Lateral Sclerosis Center, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pierri</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pili</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute of Neurology, University Hospital of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pateri</LastName><ForeName>Ida</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Institute of Neurology, University Hospital of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pilotto</LastName><ForeName>Silvy</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Neurology, University Hospital of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ercoli</LastName><ForeName>Tommaso</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-3260-1754</Identifier><AffiliationInfo><Affiliation>Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muroni</LastName><ForeName>Antonella</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Neurology, University Hospital of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chi&#xf2;</LastName><ForeName>Adriano</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Amyotrophic Lateral Sclerosis Center, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Defazio</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute of Neurology, University Hospital of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amyotrophic Lateral Sclerosis Center, University of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Muscle Nerve</MedlineTA><NlmUniqueID>7803146</NlmUniqueID><ISSNLinking>0148-639X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016000" MajorTopicYN="N">Cluster Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">incidence</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword><Keyword MajorTopicYN="N">spatial clustering</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>19</Day><Hour>13</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>19</Day><Hour>6</Hour><Minute>39</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37466098</ArticleId><ArticleId IdType="doi">10.1002/mus.27939</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Goutman SA, Hardiman O, Al-Chalabi A, et al. Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis. Lancet Neurol. 2022;21:465-479. doi:10.1016/S1474-4422(21)00414-2</Citation></Reference><Reference><Citation>Kim G, Gautier O, Tassoni-Tsuchida E, Ma XR, Gitler AD. ALS genetics: gains, losses, and implications for future therapies. Neuron. 2020;108:822-842. doi:10.1016/j.neuron.2020.08.022</Citation></Reference><Reference><Citation>Garzillo EM, Miraglia N, Pedata P, Feola D, Lamberti M. Risk agents related to work and amyotrophic lateral sclerosis: an occupational medicine focus. Int J Occup Med Environ Health. 2016;29:355-367. doi:10.13075/ijomeh.1896.00368</Citation></Reference><Reference><Citation>Andrew AS, Caller TA, Tandan R, et al. Environmental and occupational exposures and amyotrophic lateral sclerosis in New England. Neurodegener Dis. 2017;17:110-116. doi:10.1159/000453359</Citation></Reference><Reference><Citation>Filippini T, Tesauro M, Fiore M, et al. Environmental and occupational risk factors of amyotrophic lateral sclerosis: a population-based case-control study. Int J Environ Res Public Health. 2020;17:2882. doi:10.3390/ijerph17082882</Citation></Reference><Reference><Citation>Gunnarsson L-G, Bodin L. Amyotrophic lateral sclerosis and occupational exposures: a systematic literature review and meta-analyses. Int J Environ Res Public Health. 2018;15:2371. doi:10.3390/ijerph15112371</Citation></Reference><Reference><Citation>Koeman T, Slottje P, Schouten LJ, et al. Occupational exposure and amyotrophic lateral sclerosis in a prospective cohort. Occup Environ Med. 2017;74:578-585. doi:10.1136/oemed-2016-103780</Citation></Reference><Reference><Citation>Nicoletti A, Vasta R, Venti V, et al. The epidemiology of amyotrophic lateral sclerosis in the Mount Etna region: a possible pathogenic role of volcanogenic metals. Eur J Neurol. 2016;23:964-972. doi:10.1111/ene.12973</Citation></Reference><Reference><Citation>Caller TA, Doolin JW, Haney JF, et al. A cluster of amyotrophic lateral sclerosis in New Hampshire: a possible role for toxic cyanobacteria blooms. Amyotroph Lateral Scler. 2009;10(Suppl 2):101-108. doi:10.3109/17482960903278485</Citation></Reference><Reference><Citation>Masseret E, Banack S, Boum&#xe9;di&#xe8;ne F, et al. Dietary BMAA exposure in an amyotrophic lateral sclerosis cluster from Southern France. PloS One. 2013;8:e83406. doi:10.1371/journal.pone.0083406</Citation></Reference><Reference><Citation>Turabelidze G, Zhu B-P, Schootman M, et al. An epidemiologic investigation of amyotrophic lateral sclerosis in Jefferson County, Missouri, 1998-2002. Neurotoxicology. 2008;29:81-86. doi:10.1016/j.neuro.2007.09.003</Citation></Reference><Reference><Citation>Doi Y, Yokoyama T, Tango T, Takahashi K, Fujimoto K, Nakano I. Temporal trends and geographic clusters of mortality from amyotrophic lateral sclerosis in Japan, 1995-2004. J Neurol Sci. 2010;298:78-84. doi:10.1016/j.jns.2010.08.004</Citation></Reference><Reference><Citation>Boum&#xe9;di&#xe8;ne F, Druet-Cabanac M, Marin B, Preux P-M, All&#xe9;e P, Couratier P. Contribution of geolocalisation to neuroepidemiological studies: incidence of ALS and environmental factors in Limousin, France. J Neurol Sci. 2011;309:115-122. doi:10.1016/j.jns.2011.07.002</Citation></Reference><Reference><Citation>Scott KM, Abhinav K, Stanton BR, et al. Geographical clustering of amyotrophic lateral sclerosis in South-East England: a population study. Neuroepidemiology. 2009;32:81-88. doi:10.1159/000177032</Citation></Reference><Reference><Citation>Borghero G, Pierri V, Vasta R, et al. Incidence of amyotrophic lateral sclerosis in Sardinia, Italy: age-sex interaction and spatial-temporal variability. Amyotroph Lateral Scler Frontotemporal Degener. 2022;23:585-591. doi:10.1080/21678421.2022.2041670</Citation></Reference><Reference><Citation>Borghero G, Pugliatti M, Marrosu F, et al. Genetic architecture of ALS in Sardinia. Neurobiol Aging. 2014;35:2882. doi:10.1016/j.neurobiolaging.2014.07.012</Citation></Reference><Reference><Citation>Italian Statistical Institute. www.istat.it</Citation></Reference><Reference><Citation>Chio A, Calvo A, Moglia C, Mazzini L, Mora G. Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2011;82:740-746. doi:10.1136/jnnp.2010.235952</Citation></Reference><Reference><Citation>Kulldorff M. A spatial scan statistic. Commun Stat Theory Meth. 1997;26:1848. doi:10.1007/978-3-319-17885-1_101147</Citation></Reference><Reference><Citation>Szklo M, Nieto FJ. Epidemiology: beyond the basics. 4th ed. Jones &amp; Bartlett Learning; 2020. doi:10.1249/01.mss.0000617900.65045.1a</Citation></Reference><Reference><Citation>Sahai H, Khurshid A. Formulae and tables for the determination of sample sizes and power in clinical trials for testing differences in proportions for the two-sample design: a review. Stat Med. 1996;15:1-21. doi:10.1002/(SICI)1097-0258(19960115)15:1&lt;1::AID-SIM134&gt;3.0.CO;2-E</Citation></Reference><Reference><Citation>Chi&#xf2; A, Moglia C, Canosa A, et al. ALS phenotype is influenced by age, sex, and genetics. Neurology. 2020;94:e802-e810. doi:10.1212/WNL.0000000000008869</Citation></Reference><Reference><Citation>Orr&#xf9; S, Manolakos E, Orr&#xf9; N, et al. High frequency of the TARDBP p.Ala382Thr mutation in Sardinian patients with amyotrophic lateral sclerosis. Clin Genet. 2012;81:172-178. doi:10.1111/j.1399-0004.2011.01668.x</Citation></Reference><Reference><Citation>Pugliatti M, Parish LD, Cossu P, et al. Amyotrophic lateral sclerosis in Sardinia, insular Italy, 1995-2009. J Neurol. 2013;260:572-579. doi:10.1007/s00415-012-6681-5</Citation></Reference><Reference><Citation>Borghero G, Pugliatti M, Marrosu F, et al. TBK1 is associated with ALS and ALS-FTD in Sardinian patients. Neurobiol Aging. 2016;43:180.e1-180.e5. doi:10.1016/j.neurobiolaging.2016.03.028</Citation></Reference><Reference><Citation>Borghero G, Pugliatti M, Marrosu F, et al. ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry. Neurobiol Aging. 2015;36:2906-2905. doi:10.1016/j.neurobiolaging.2015.06.013</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>